Current Capabilities and Services

This facility helps UC San Diego and external investigators transition cell therapies through IND-enabling and Phase I/II clinical studies.  The ACTL features the following capabilities:

•Optimizing manufacturing processes, including scale-up, closed systems, and delivery formats

•Development of Standard Operating Procedures and Batch Production Records

•Cell product manufacturing, including cell enrichment with the CliniMACS System

•Cell product characterization, including standard microbiological release assays, flow cytometry and RT-qPCR assessment 

•Secure storage of cell banks and cell products

•Materials risk assessment and selection

•Writing or review of CMC or supporting reports